Filter
2431
Filtered Results: 2431
Text search:
Pharmaceuticals
Featured
Recommendations
223
New Publications
633
Language
Document type
No document type
1188
Studies & Reports
468
Guidelines
389
Manuals
111
Strategic & Response Plan
107
Fact sheets
65
Training Material
33
Resource Platforms
21
Situation Updates
20
Infographics
14
Brochures
9
Online Courses
6
Countries / Regions
Kenya
98
Global
96
Ethiopia
90
India
88
South Africa
58
Western and Central Europe
51
Nigeria
49
Liberia
42
Uganda
42
Sierra Leone
40
Rwanda
35
Nepal
34
Ghana
32
Tanzania
30
Namibia
30
Africa
30
Zambia
29
Malawi
29
Bangladesh
28
Ukraine
27
Latin America and the Carribbean
25
Philippines
22
Germany
21
Eastern Europe
21
Zimbabwe
20
Indonesia
19
Syria
18
Cambodia
17
Lesotho
17
South–East Asia Region
17
Congo, Democratic Republic of
16
Myanmar / Burma
16
West and Central Africa
14
Eswatini/ Swaziland
13
Botswana
13
Russia
12
Eastern Europe and Central Asia
11
East and Southern Africa
10
Guinea
9
South Sudan
9
Asia
9
Venezuela
9
Senegal
8
Cameroon
8
Brazil
8
Burkina Faso
7
Mozambique
7
Benin
7
Middle East and North Africa
7
Haiti
6
Thailand
6
Chile
6
Western Pacific Region
6
Pakistan
5
Papua New Guinea
5
Albania
5
Vietnam
5
Sudan
4
Madagascar
4
Laos
4
Mali
3
USA
3
Jordan
3
Afghanistan
3
Lebanon
3
Egypt
3
China
3
Peru
3
North Macedonia
3
Angola
3
Fiji
3
Tajikistan
3
North America
3
United Kingdom
3
Iraq
2
Central African Republic
2
Argentina
2
Serbia
2
Bolivia
2
Yemen
2
Paraguay
2
Southern Africa
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Spain
2
Guinea-Bissau
1
Saudi Arabia
1
Niger
1
Somalia
1
Chad
1
Malaysia
1
Ireland
1
Colombia
1
Ecuador
1
El Salvador
1
Libya
1
Sri Lanka
1
Bhutan
1
Palestine
1
Armenia
1
Mongolia
1
Canada
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
978
Clinical Guidelines
149
Public Health
120
Key Resources
85
Women & Child Health
57
Pharmacy & Technologies
42
Capacity Building
18
Annual Report MEDBOX
2
Toolboxes
Pharmacy
248
COVID-19
240
AMR
228
Mental Health
133
HIV
116
TB
110
Rapid Response
67
Planetary Health
63
NTDs
58
NCDs
58
Caregiver
48
Ebola
45
Global Health Education
42
Conflict
40
Health Financing Toolbox
35
Refugee
25
Disability
18
Specific Hazards
14
Natural Hazards
13
Polio
12
Social Ethics
5
Cholera
4
Zika
4
Health Financing
2
South Sudan
1
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
PLoS Negl Trop Dis 14(1): e0007999. January 30, 2020 is the first-ever World Neglected Tropical Diseases Day (World NTD Day), a day when we celebrate the achievements made towards control of the world’s NTDs, yet recognize the daunting challenges we face in the control and elimination of these con...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Japan has been implementing projects of global extension of medical technologies under an official development assistance policy to improve public health and medicine by promoting Japanese medical technologies worldwide. The current work examines the impact and goals of implementing this new scheme....
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research with human beings. This supervision includes the ac...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
The scope of this PPC document is to serve as a guide to address the unmet public health need for a PPE system that protects the HW-F in tropical climate
s while caring for patients and providing heavy duty essential health services.
The characteristics described in this guidance are targeted fo...
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
AWaRe – a new WHO tool to help countries improve antibiotic treatment, increase access and reduce resistance. We can reduce or even reverse antibiotic resistance by using antibiotics more responsibly. But how do we do that and still ensure that patients are treated effectively?WHO has developed a ...
